Literature DB >> 10086740

TEL-AML1 fusion transcript designates a favorable outcome with an intensified protocol in childhood acute lymphoblastic leukemia.

S Avigad, G Kuperstein, J Zilberstein, E Liberzon, B Stark, I Gelernter, Y Kodman, D Luria, S Ash, J Stein, Y Goshen, I Yaniv, I J Cohen, R Zaizov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10086740     DOI： 10.1038/sj.leu.2401313

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  2 in total

1.  Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials.

Authors:  C Piette; S Suciu; E Clappier; Y Bertrand; S Drunat; S Girard; K Yakouben; G Plat; N Dastugue; F Mazingue; N Grardel; N van Roy; A Uyttebroeck; V Costa; O Minckes; N Sirvent; P Simon; P Lutz; A Ferster; C Pluchart; M Poirée; C Freycon; M-F Dresse; F Millot; C Chantrain; J van der Werff Ten Bosch; K Norga; C Gilotay; P-S Rohrlich; Y Benoit; H Cavé
Journal:  Leukemia       Date:  2017-09-19       Impact factor: 11.528

2.  Determination of ETV6-RUNX1 genomic breakpoint by next-generation sequencing.

Authors:  Yanliang Jin; Xingwei Wang; Shaoyan Hu; Jingyan Tang; Benshang Li; Yihuan Chai
Journal:  Cancer Med       Date:  2015-12-29       Impact factor: 4.452
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.